Haleon (NYSE: HLN) CFO and CEO acquire shares and ADSs through dividend reinvestment

Rhea-AI Filing Summary

Haleon plc reported routine share acquisitions by two senior executives through dividend reinvestment plans. Chief Financial Officer Dawn Allen acquired 2,596.07411 ordinary shares at £3.4022 per share on 19 May 2026 on the London Stock Exchange. Chief Executive Officer Brian McNamara acquired 24,891.04716 ordinary shares at the same £3.4022 price on the London Stock Exchange and 4,414.93735 American Depositary Shares at $9.2446 each on the New York Stock Exchange, also on 19 May 2026. These transactions reflect automatic reinvestment of cash dividends into additional equity in Haleon.

Key Figures

CFO ordinary shares acquired: 2,596.07411 shares at £3.4022 CEO ordinary shares acquired: 24,891.04716 shares at £3.4022 CEO ADSs acquired: 4,414.93735 ADSs at $9.2446 +1 more

4 metrics

CFO ordinary shares acquired 2,596.07411 shares at £3.4022 Dividend reinvestment on 19 May 2026, London Stock Exchange

CEO ordinary shares acquired 24,891.04716 shares at £3.4022 Dividend reinvestment on 19 May 2026, London Stock Exchange

CEO ADSs acquired 4,414.93735 ADSs at $9.2446 Dividend reinvestment on 19 May 2026, New York Stock Exchange

Issuer LEI 549300PSB3WWEODCUP19 Legal Entity Identifier for Haleon plc

Key Terms

Persons Discharging Managerial Responsibilities, Market Abuse Regulation, dividend reinvestment, American Depositary Shares, +1 more

5 terms

Persons Discharging Managerial Responsibilities regulatory

"Transactions by Persons Discharging Managerial Responsibilities ("PDMRs")."

Persons Discharging Managerial Responsibilities are the key people in a company who make big decisions, like top managers or executives. Knowing who they are is important because their actions can influence the company’s success or failure, and they are often required to share information about their dealings to ensure transparency for investors and the public.

Market Abuse Regulation regulatory

"in accordance with the requirements of The UK Market Abuse Regulation"

Market abuse regulation consists of laws and rules designed to prevent dishonest or manipulative practices in financial markets. It aims to ensure fair and transparent trading, so investors can trust that markets operate honestly, much like rules that keep a game fair. By reducing unfair advantages, it helps protect investor confidence and promotes healthy, efficient markets.

dividend reinvestment financial

"Acquisition of Ordinary Shares as a result of dividend reinvestment"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

American Depositary Shares financial

"Acquisition of ADSs as a result of dividend reinvestment"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

LEI regulatory

"b) | LEI | 549300PSB3WWEODCUP19"

A Legal Entity Identifier (LEI) is a unique 20-character code assigned to a company or organization that participates in financial markets, like a corporate passport number. It helps investors and regulators unambiguously identify counterparties across databases and transactions, reducing confusion much like using a vehicle identification number to track a car’s history; clearer identification improves transparency, risk monitoring, and regulatory reporting.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2026

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	22 May 2026 - Director/PDMR Shareholding

99.1

​Haleon plc: Director/PDMR Shareholding

​

​22 May 2026: Haleon plc (the “Company” or “Haleon”) (LSE/NYSE:HLN) today announces notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs").

On 21 May 2026, the Company was notified of the following transactions as detailed below.

1	Details of the issuer, emission allowance market participant
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification /Amendment	Initial Notification
3	Details of the person discharging managerial responsibilities / person closely associated (“PCA”)
a)	PDMR/PCA	PDMR
b)	Name	Dawn Allen
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of Instrument Identification code	Share GB00BMX86B70
b)	Nature of the transaction	Acquisition of Ordinary Shares as a result of dividend reinvestment
c)	Currency, Price(s) and volume(s)	Price(s)	Volume(s)
		£3.4022	2,596.07411
d)	Aggregated information   - Aggregated volume  - Price	N/A
e)	Date of the transaction	19 May 2026
f)	Place of the transaction	London Stock Exchange (XLON)

1	Details of the issuer, emission allowance market participant
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial Notification
3	Details of the person discharging managerial responsibilities / person closely associated (“PCA”)
a)	PDMR/PCA	PDMR
b)	Name	Brian McNamara
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of Instrument   Identification code	Share GB00BMX86B70
b)	Nature of the transaction	Acquisition of Ordinary Shares as a result of dividend reinvestment
c)	Currency, Price(s) and volume(s)	Price(s)	Volume(s)
		£3.4022	24,891.04716
d)	Aggregated information   - Aggregated volume  - Price	N/A
e)	Date of the transaction	19 May 2026
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of Instrument Identification code	Share US4055521003
b)	Nature of the transaction	Acquisition of ADSs as a result of dividend reinvestment
c)	Currency, Price(s) and volume(s)	Price(s)	Volume(s)
		$9.2446	4,414.93735
d)	Aggregated information   - Aggregated volume  - Price	N/A
e)	Date of the transaction	19 May 2026
f)	Place of the transaction	New York Stock Exchange (XNYS)

Amanda Mellor

Company Secretary

About Haleon

Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren – are trusted by more than one billion consumers and are recommended by health professionals around the world.

For more information, please visit www.haleon.com. 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: May 22, 2026	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary

FAQ

What insider share transactions did Haleon (HLN) disclose in this 6-K?

Haleon disclosed that its CFO and CEO acquired additional equity through dividend reinvestment. Both executives received ordinary shares, and the CEO also received ADSs, as cash dividends were automatically reinvested into Haleon securities on 19 May 2026.

How many Haleon shares did CFO Dawn Allen acquire via dividend reinvestment?

CFO Dawn Allen acquired 2,596.07411 Haleon ordinary shares through dividend reinvestment. The shares were bought at £3.4022 per share on 19 May 2026 and were transacted on the London Stock Exchange, increasing her equity exposure through an automatic plan.

What Haleon share and ADS purchases were reported for CEO Brian McNamara?

CEO Brian McNamara acquired 24,891.04716 Haleon ordinary shares at £3.4022 on the London Stock Exchange and 4,414.93735 American Depositary Shares at $9.2446 on the New York Stock Exchange, all through dividend reinvestment on 19 May 2026.

Were the Haleon insider acquisitions open-market buys or dividend reinvestments?

The transactions were dividend reinvestments, not discretionary open-market purchases. Cash dividends owed to Haleon’s CFO and CEO were automatically used to buy additional ordinary shares and ADSs on 19 May 2026 under dividend reinvestment arrangements.

On which exchanges were the Haleon insider transactions executed?

The ordinary share acquisitions for both executives occurred on the London Stock Exchange (XLON). The CEO’s American Depositary Share acquisition took place on the New York Stock Exchange (XNYS), reflecting Haleon’s dual listing in London and New York.

Why did Haleon (HLN) issue this notification about PDMR transactions?

Haleon issued the notification to comply with UK Market Abuse Regulation rules. Transactions by Persons Discharging Managerial Responsibilities must be publicly disclosed, so the company reported the dividend reinvestment acquisitions by its CFO and CEO in this 6-K filing.